Shoulder Innovations received FDA 510(k) clearance to market the InSet Humeral Short Stem system for total and partial shoulder arthroplasty.
The InSet Shoulder features streamlined instrumentation and a proprietary coating for implant fixation. It can be used with the company's InSet glenoid implant as a bone-sparing option to treat humeral or glenoid deformities.
Last month, the company closed a US $2.5MM round of Series A equity funding to support new product development and growth of its InSet platform, including acquisition of inventory and assets.
Sources: Shoulder Innovations, LLC; ORTHOWORLD Inc.